SI-BONE, Inc.

Name: SI-BONE, Inc. standardized financial statements, quarterly
Creator: Listed

SIBNNasdaqCIK 1459839HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$56.0m, Q2 FY2026

Operating income−$4.8m, Q2 FY2026

Net income−$4.1m, Q2 FY2026

SI-BONE, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	34.0	38.9	37.9	40.0	40.3	49.0	47.3	48.6	48.7	56.3	52.6	56.0
Cost of revenue	$m	7.0	10.2	8.0	8.4	8.4	10.2	9.6	9.8	9.8	11.8	10.6	11.5
Gross profit	$m	27.0	28.7	29.9	31.6	31.9	38.8	37.7	38.8	38.8	44.5	41.9	44.5
Research and development	$m	3.9	4.2	4.3	4.4	4.0	3.9	4.5	4.3	4.2	4.4	4.2	5.2
Operating income	$m	(11.2)	(12.5)	(12.0)	(10.1)	(7.6)	(5.5)	(7.5)	(7.0)	(5.4)	(2.5)	(5.1)	(4.8)
Interest expense	$m	0.9	0.9	0.9	0.9	0.9	0.8	0.7	0.7	0.7	0.6	0.6	0.6
Income tax	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(10.0)	(11.0)	(10.9)	(8.9)	(6.6)	(4.5)	(6.5)	(6.2)	(4.6)	(1.6)	(4.3)	(4.1)
Diluted EPS	$ per share	(0.25)	not reported	(0.27)	(0.22)	(0.16)	not reported	(0.15)	(0.14)	(0.11)	not reported	(0.10)	(0.09)
Basic EPS	$ per share	(0.25)	not reported	(0.27)	(0.22)	(0.16)	not reported	(0.15)	(0.14)	(0.11)	not reported	(0.10)	(0.09)

Balance sheet

Cash and equivalents$33.1m, Q2 FY2026

Long-term debt$35.6m, Q2 FY2026

Shareholders' equity$182.3m, Q2 FY2026

SI-BONE, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	53.5	33.3	32.0	25.6	30.2	34.9	41.2	34.2	26.5	42.2	33.5	33.1
Current assets	$m	211	211	204	202	204	208	204	207	211	216	215	220
Total assets	$m	231	230	224	224	227	230	227	231	234	239	243	249
Current liabilities	$m	19.4	23.5	20.9	22.1	24.7	27.1	24.0	24.8	26.4	25.3	21.5	24.0
Total liabilities	$m	57.3	61.1	58.2	59.1	62.0	63.5	60.0	60.6	62.1	61.0	63.8	66.4
Long-term debt	$m	36.0	36.1	36.1	36.1	36.2	35.5	35.5	35.5	35.5	35.6	35.6	35.6
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	174	169	166	165	165	167	167	170	172	178	179	182

Cash flow

Operating cash flow$777.0k, Q2 FY2026

Capital expenditure$1.5m, Q2 FY2026

SI-BONE, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(2,073)	(2,297)	(7,571)	(6,334)	302	1,178	(4,911)	173	2,335	1,728	(2,362)	777
Capital expenditure	$k	1,413	1,093	2,082	3,113	3,036	2,266	2,072	2,099	2,955	1,288	1,077	1,545

Diluted shares (weighted)44.48m, Q2 FY2026

SI-BONE, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	34.4	34.9	37.9	40.3	40.9	41.3	41.7	42.3	42.8	43.2	44.0	44.5

Shares outstanding: 44.82m at Jul 29, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.